Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Amy Grossberndt"'
Autor:
Andrew Gomori, Meghann Klowak, Michael Prout, Farid Esfahani, Michael Namaka, Romeo Hizon, Amy Grossberndt, Christine Leong, Michael R. Mulvey, Loressa Klassen, Maria Melanson, Malcolm Doupe, Aneri Gupta, Emma E. Frost
Publikováno v:
Multiple Sclerosis Journal. 17:397-403
Background: Staphylococcus aureus may produce superantigens that can non-specifically activate CD4+ cells to potentially target the myelin basic protein. Objective: This study examined the association between individuals with multiple sclerosis (MS)
Autor:
Michael Prout, Michael Namaka, Andrew Gomori, Meghann Klowak, Maria Melanson, Emma E. Frost, Colin R. Gramlich, Lisa Wong, Malcom Doupe, Amy Grossberndt, Christine Leong, Farid Esfahani, Josee-Anne Le Dorze
Publikováno v:
International Journal of Neuroscience. 120:631-640
Fatigue and cognitive deficits are common symptoms affecting patients with multiple sclerosis.The effects of interferon beta on fatigue and cognitive deficits were assessed in 50 patients with relapsing multiple sclerosis (recruited at a single cente
Autor:
Michael Namaka, Howard Intrater, Meghann Klowak, Amy Grossberndt, Christine Leong, Andrew Gomori, Farid Esfahani, Dana Turcotte
Publikováno v:
The Consultant Pharmacist. 24:885-902
OBJECTIVE The purpose of this review is to provide an update of the neuropathic pain treatment algorithm previously published by Namaka et al. in 2004. This algorithm focuses on the strategic incorporation of the latest pain therapies while providing
Publikováno v:
The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists. 23(11)
OBJECTIVE To review the etiology and treatment strategies for multiple sclerosis (MS). DATA SOURCES Published information on MS and targeted treatment strategies extending back to 1955. The search terms multiple sclerosis and pathology, prevalence, g
Autor:
Amy Grossberndt, Meghann Klowak, Christine Leong, Emma E. Frost, Dana Turcotte, M.J. Melanson, Michael Prout, L. Vuong, S. Andresen, Mike Namaka, Malcolm Doupe, J-A. Le Dorze
Publikováno v:
Clinical Medicine Insights: Therapeutics, Vol 2011, Iss 3, Pp 449-458 (2011)
Clinical Medicine Insights: Therapeutics, Vol 3 (2011)
Clinical Medicine Insights: Therapeutics, Vol 3 (2011)
Background and purposeMitoxantrone (MX) (Novantrone®) is approved in Canada for certain refractory cancers and acute non-lymphocytic leukemias. It has FDA approval as an immunomodulatory agent for use in secondary progressive multiple sclerosis (SPM
Autor:
Ewa Leligdowicz, Amy Grossberndt, Christine Leong, Jenny Drummond, Mike Namaka, Meghann Klowak, Melanie Lichkowski, Christopher Louizos, Maria Melanson
Publikováno v:
Canadian Pharmacists Journal / Revue des Pharmaciens du Canada. 142:190-198.e1
Introduction Triptans, ergotamine derivatives and nonsteroidal anti-inflammatory drugs are front-line agents used in the acute abortive therapy of migraines. In this article, these medications are reviewed and a treatment algorithm suggested. Methods